The Importance of Sleep for Diabetes Associated Tasks and Outcomes
Sleep1child
Sleep1child
Sponsor study identifier
observational
77
1 country
1
Study Start
March 27, 2023
Actual (reported)Primary Completion
April 16, 2024
Actual (reported)Study Completion
April 16, 2024
Actual (reported)Adolescents with type 1 diabetes (T1D) experience more disturbed sleep compared to their healthy peers, especially because they tend to spend less time in deep sleep, the most restoring part of sleep, potentially impacting diabetes management. Disturbed sleep may adversely affect diabetes management which requires day-to-day decision-making, emotional and behavioural regulation, attention, and planning. Despite a massive increase in new technology, more than 50% of adolescents do not reach their glycaemic target. Lack of sleep impairing diabetes management including blood glucose monitoring may play an important role in reaching the goal. For approximately 4000 children and adolescents in Denmark living with T1D, sleep disturbances may therefore account for short and long-term diabetes complications. Our overall aims are to investigate: (1) If and how glycaemic variability (GV) influences sleep quality and sleep stages and (2) if and how poor sleep quality influences time-in-range (TIR), time-above-range (TAR) and time-below-range (TBR) the following day.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 16, 2024
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 16, 2023
Actual (reported)March 10, 2023
Actual (reported)March 27, 2023
Actual (reported)April 16, 2024
Actual (reported)April 16, 2024
Actual (reported)Sleep quality
% of total sleep time in deep sleep (stage N3 and N4)
In the the study periode (one to maksimum five nights)
Daytime time-in-range (TIR)
3,9-10 mmol/L
In the study periode (7 days)
Children and adolescents with type 1 diabetes (T1D) 6 to 17 years old, which have had the disease for over 6 months and use both an insulin pump and a continuous glucose monitor. One or both parents and healthy siblings are also included, but this is not a demand.
Steno Diabetes Center Copenhagen
Herlev, 2730, Denmark
Jannet Svensson, Professor
Steno Diabetes Center Copenhagen
77 participants (actual enrollment reported by the registry).
First Submitted
February 16, 2023
First Posted
March 10, 2023
Study Start
March 27, 2023
Actual (reported)Morning Versus Afternoon Aerobic Exercise in Type 1 Diabetes
Contact the study team to confirm eligibility.
Primary Completion
April 16, 2024
Actual (reported)Study Completion
April 16, 2024
Actual (reported)Last Updated
April 18, 2024
Record last verified: 2024-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: